The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 25, 2021

Filed:

Jul. 01, 2009
Applicant:

Joan M. Fallon, White Plains, NY (US);

Inventor:

Joan M. Fallon, White Plains, NY (US);

Assignee:

CUREMARK, LLC, Rye Brook, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); A61P 25/18 (2006.01); A61K 38/50 (2006.01); A61K 38/47 (2006.01); A61K 38/48 (2006.01); A61K 38/46 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); A61K 38/465 (2013.01); A61K 38/47 (2013.01); A61K 38/48 (2013.01); A61K 38/488 (2013.01); A61K 38/4826 (2013.01); A61K 38/4873 (2013.01); A61K 38/50 (2013.01); G01N 2333/976 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/304 (2013.01);
Abstract

A therapeutic composition for the treatment of the symptoms of neurological and mental health disorders, such as Alzheimer's, bipolar disorder, obsessive compulsive disorder, and oppositional defiant disorder, and the method for preparing the therapeutic agents is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using fecal chymotrypsin level as an indicator of the presence of neurological and mental health disorders, such as Alzheimer's, bipolar disorder, obsessive compulsive disorder, and oppositional defiant disorder, or the likelihood of an individual to develop these disorders is disclosed.


Find Patent Forward Citations

Loading…